NCPA to launch site for independent pharmacy buyers and sellers
September 21st 2010A new website being launched by the National Community Pharmacists Association (NCPA), www.PharmacyMatching.com, will bring together independent pharmacy owners preparing to sell their pharmacies, existing owners who desire additional stores, and entrepreneurs seeking to become pharmacy owners.
Ferring Pharmaceuticals joins race to fight prostate cancer
September 21st 2010Ferring Pharmaceuticals Inc. is in the race to end prostate cancer as an official sponsor of the Great Prostate Cancer Challenge/Dash for Dad, a series of races in the United States, led by ZERO ? The Project to End Prostate Cancer.
Kerr Drug launches comprehensive immunization program for flu season
September 21st 2010Kerr Drug, a community pharmacy that pioneered the training of clinical pharmacists to administer vaccines to patients, is launching an effort to meet the demand for flu shots. The company is beginning its flu shot campaign earlier than ever this year and providing vaccinations during operating hours at all its stores throughout North Carolina, with no appointments necessary.
Hospitalizations decline for peptic ulcer disease, H. pylori infection
September 21st 2010Hospitalization rates for peptic ulcer disease and Helicobacter pylori infection have decreased substantially since 1998, according to an analysis in the September issue of Emerging Infectious Diseases, HealthDay News reported.
CPOE warning system may reduce orders for inappropriate meds
September 21st 2010The implementation of a computerized provider order entry (CPOE) drug warning system can reduce orders for potentially inappropriate medications in hospitalized older patients, according to a study published in the Aug. 9 issue of the Archives of Internal Medicine, HealthDay News reported.
CDER speakers to address cardiovascular safety, diabetic drug development
September 21st 2010The Drug Information Association, in collaboration with FDA and the Cardiac Research Safety Consortium, will host Development of Type 2 Diabetes Mellitus Drugs Conference: State-of-the-Art Cardiovascular Safety Assessments, Oct. 5?6 in Washington, D.C.
Bisphosphonate exposure not linked to esophageal cancer
September 21st 2010There appears to be no association between the use of oral bisphosphonates and the risk of esophageal or gastric cancer, according to research published in the Aug. 11 issue of the Journal of the American Medical Association, HealthDay News reported.
FDA warns of aseptic meningitis risk with use of lamotrigine
September 21st 2010FDA issued a warning Aug. 12 that the drug lamotrigine (Lamictal, GlaxoSmithKline), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation not caused by bacterial infection of the protective membranes (meninges) that cover the brain and spinal cord.
Associations in favor of CMS proposed rule revising Medicaid pharmacy reimbursement formula
September 21st 2010Both the National Association of Chain Drug Stores and National Community Pharmacists Association favor the proposed rule by the Centers for Medicare & Medicaid Services (CMS) that would withdraw existing provisions of the Medicaid pharmacy reimbursement formula under the average manufacturer price (AMP) model.
FDA continues scrutiny of DTC genetic tests
September 15th 2010Underlying a recent FDA-hosted public meeting and workshop was the question of how FDA as a regulatory agency should increase its current oversight of clinical laboratories, specifically those developing genetic tests that may be offered at their own facilities or made available through direct-to-consumer channels.
Monitoring controlled substances
September 15th 2010Thirty-nine states now have a tool to help pharmacists identify at least some questionable prescriptions and suggest when a patient may be doctor-shopping or pharmacy-shopping in order to obtain controlled substances. That tool is the state prescription monitoring program.
FDA panel rejects REMS proposal for long-acting opioids
September 15th 2010FDA advisory committee members voted 25 to 10 to reject a proposed plan to establish a risk evaluation and mitigation strategy for extended-release and long-acting opioid analgesics during the joint meeting on July 23 of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee in Adelphi, Md.
Local pharmacists: Serving their communities
September 15th 2010Patients often bring their own set of challenges with them to the pharmacy counter and community pharmacists have taken notice. Many have responded by creating programs that not only help patients secure the medication they need, but also offer them ways to make the most of their treatment plans.
Plavix biomarker test can improve patient outcomes
September 15th 2010In a novel collaboration with PBM giant CVS Caremark and its specialty pharmacy Generation Health, PGXL Laboratories will use its expertise in anticoagulants to improve the quality of patient care through pharmacogenetic testing, physician education, and drug-specific software programs.
State deals setback in drive to end pharmacy ownership restrictions in North Dakota
August 17th 2010The North Dakota secretary of state rejected thousands of signatures from a petition that would have put a measure on the November ballot to end the state?s restrictions on pharmacy ownership, the Associated Press reported.
FDA approves longer Valcyte therapy for CMV disease in adult kidney-transplant patients
August 17th 2010FDA approved increasing the length of therapy with Valcyte (valganciclovir hydrochloride) in adult kidney-transplant patients at high risk for cytomegalovirus (CMV) disease, according to an Aug. 10 statement made by Genentech Inc.
Hospital-acquired MRSA infections decline between 2005 and 2008
August 17th 2010Infections with the deadly methicillin-resistant Staphylococcus aureus (MRSA) bacteria contracted in hospitals and other healthcare settings have declined 28% over a 4-year period, according to a new Centers for Disease Control and Prevention (CDC) study of about 15 million people.